California SB1094 mandates health insurers to cover biosimilar and interchangeable biological products, promoting cost-effective and safe.

California SB1094 requires health insurers to cover biosimilar and interchangeable biological products, ensuring access to cost-effective alternatives. Insurers must include biosimilars on their formularies if they have a lower net cost. Pharmacists can substitute these products unless a prescriber indicates "Do not substitute." Insurers must notify prescribers about biosimilar alternatives and provide details on cost sharing and exceptions. The bill aims to promote affordable and safe treatments for Californians.

California SB1094 mandates health insurers to cover biosimilar and interchangeable biological products, promoting cost-effective and safe.

California SB1094 requires health insurers to cover biosimilar and interchangeable biological products, ensuring access to cost-effective alternatives. Insurers must include biosimilars on their formularies if they have a lower net cost. Pharmacists can substitute these products unless a prescriber indicates "Do not substitute." Insurers must notify prescribers about biosimilar alternatives and provide details on cost sharing and exceptions. The bill aims to promote affordable and safe treatments for Californians.